 |
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
FDA is reminding patients who use fentanyl transdermal system pain patches (Duragesic and its generics) to always store, use, and dispose of them carefully to prevent unintended poisonings and other harm, especially to children and pets.
Fentanyl is a strong medicine used to relieve severe pain, and the patches should only be handled by the patient or the patient’s caregivers. Many patients don’t know that a patch they have worn for 3 days still contains enough fentanyl to cause harm, or even kill a child or pet.
Learn more about how to safely use and dispose of these patches and how to protect others by talking to your health care practitioner or pharmacist or by visiting FDA’s Fentanyl Transdermal System (marketed as Duragesic) Information and Disposal of Unused Medicines: What You Should Know web pages.
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@fda.hhs.gov.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
